BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19458303)

  • 21. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
    Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.
    Santos C; Pérez-Fontán M; Rodríguez-Carmona A; Calvo-Rodríguez M; López-Muñiz A; López-Calviño B; García-Falcón T
    Perit Dial Int; 2016; 36(1):43-51. PubMed ID: 25292406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients.
    Johnson DW; van Eps C; Mudge DW; Wiggins KJ; Armstrong K; Hawley CM; Campbell SB; Isbel NM; Nimmo GR; Gibbs H
    J Am Soc Nephrol; 2005 May; 16(5):1456-62. PubMed ID: 15788475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HONEYPOT randomized controlled trial statistical analysis plan.
    Pascoe EM; Lo S; Scaria A; Badve SV; Beller EM; Cass A; Hawley CM; Johnson DW
    Perit Dial Int; 2013; 33(4):426-35. PubMed ID: 23843589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal catheter exit-site and tunnel infections.
    Piraino B
    Adv Ren Replace Ther; 1996 Jul; 3(3):222-7. PubMed ID: 8827201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
    Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
    Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.
    Rodríguez-Carmona A; Pérez-Fontán M; López-Muñiz A; Ferreiro-Hermida T; García-Falcón T
    Perit Dial Int; 2014; 34(6):618-26. PubMed ID: 23818005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections.
    Ferreira AC; Fernandes V; Rodrigues A; Abreu CP; Pereira M; Guedes AM; Gomes AM; Cabrita A; Soares C; Pego C; Ferrer F; Bernardo I; Fernandes JC; Assunção J; Oliveira L; Amoedo M; Carvalho MJ; Branco P; Maia P; Chorão R; Castro R; Silva R; Sousa T; Mendes T;
    Blood Purif; 2023; 52(4):366-372. PubMed ID: 36702111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection Prophylaxis in Peritoneal Dialysis Patients: Results from an Australia/New Zealand Survey.
    Campbell DJ; Mudge DW; Gallagher MP; Lim WH; Ranganathan D; Saweirs W; Craig JC
    Perit Dial Int; 2017; 37(2):191-197. PubMed ID: 28096438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Strippoli GF; Tong A; Johnson D; Schena FP; Craig JC
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004679. PubMed ID: 15495124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
    Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
    Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.
    Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG
    Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Water avoidance and modification of exit-site care with stoma bag results in reduced exit-site infection rate in peritoneal dialysis patients.
    Soetendorp H; Kliuk-Ben Bassat O; Wasserman A; Schwartz D; Bedbalayev R; Faukman I; Grupper A
    Clin Nephrol; 2021 Jun; 95(6):323-331. PubMed ID: 33835011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.